HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrea Necchi Selected Research
Andrea Necchi Research Topics
Disease
118
Neoplasms (Cancer)
05/2024 - 08/2009
100
Carcinoma (Carcinomatosis)
04/2024 - 12/2013
76
Urinary Bladder Neoplasms (Bladder Cancer)
05/2024 - 08/2015
38
Neoplasm Metastasis (Metastasis)
04/2024 - 09/2013
26
Penile Neoplasms (Penile Cancer)
05/2024 - 01/2015
24
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2021 - 01/2010
22
Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2024 - 08/2011
15
Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 06/2015
15
Disease Progression
12/2022 - 02/2015
12
Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2020
9
Seminoma
01/2023 - 06/2016
7
Non-Muscle Invasive Bladder Neoplasms
05/2024 - 01/2018
7
Kidney Neoplasms (Kidney Cancer)
10/2023 - 12/2018
7
Microsatellite Instability
01/2023 - 01/2019
5
Urologic Neoplasms (Urological Cancer)
01/2023 - 10/2019
4
Lymphatic Metastasis
01/2021 - 01/2015
3
Carcinoma in Situ
05/2024 - 01/2017
3
Pathologic Complete Response
01/2021 - 01/2019
3
Adenocarcinoma
01/2020 - 04/2011
3
Testicular Neoplasms (Testicular Cancer)
01/2020 - 10/2011
3
Nonseminomatous germ cell tumor
11/2019 - 10/2016
2
Necrosis
11/2022 - 01/2022
2
Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2022 - 01/2022
2
Neutropenia
12/2020 - 01/2020
2
Pneumonia (Pneumonitis)
12/2020 - 05/2016
2
Pain (Aches)
11/2020 - 11/2015
2
Lymphadenopathy
01/2020 - 01/2020
Drug/Important Bio-Agent (IBA)
39
Cisplatin (Platino)
FDA Link
Generic
02/2024 - 11/2010
37
Immune Checkpoint Inhibitors
IBA
01/2024 - 05/2016
36
Platinum
IBA
04/2023 - 08/2012
32
pembrolizumab
IBA
05/2024 - 09/2016
23
Biomarkers (Surrogate Marker)
IBA
05/2024 - 05/2016
11
DNA (Deoxyribonucleic Acid)
IBA
10/2023 - 01/2019
10
atezolizumab
IBA
04/2024 - 05/2016
10
Nivolumab
IBA
02/2024 - 09/2016
9
B7-H1 Antigen
IBA
01/2023 - 01/2017
7
Gemcitabine
FDA Link
02/2024 - 02/2014
7
erdafitinib
IBA
04/2023 - 01/2019
7
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
01/2023 - 01/2019
7
Monoclonal Antibodies
IBA
10/2022 - 09/2016
7
Hemoglobins (Hemoglobin)
IBA
01/2022 - 12/2013
6
Docetaxel (Taxotere)
FDA Link
12/2023 - 01/2017
5
Ramucirumab
IBA
01/2022 - 11/2017
5
Etoposide (VP 16)
FDA Link
Generic
10/2021 - 06/2016
5
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
10/2021 - 02/2019
5
Albumins
IBA
01/2018 - 05/2014
5
taxane
IBA
01/2017 - 01/2016
4
Proteins (Proteins, Gene)
FDA Link
05/2024 - 06/2015
4
Hormones (Hormone)
IBA
12/2023 - 11/2022
4
Androgens
IBA
06/2023 - 01/2020
4
Ligands
IBA
01/2023 - 01/2017
4
enfortumab vedotin
IBA
10/2022 - 01/2021
4
Tyrosine Kinase Inhibitors
IBA
01/2022 - 11/2015
3
Circulating Tumor DNA
IBA
10/2023 - 12/2021
3
cyclopropapyrroloindole
IBA
01/2023 - 01/2018
3
Immunoconjugates (Immunoconjugate)
IBA
10/2022 - 01/2021
3
Carboplatin (JM8)
FDA Link
Generic
06/2022 - 01/2017
3
Phenobarbital (Luminal)
FDA Link
01/2022 - 01/2021
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2021 - 11/2015
3
RNA (Ribonucleic Acid)
IBA
12/2021 - 01/2018
3
Tumor Biomarkers (Tumor Markers)
IBA
06/2021 - 11/2019
3
Bleomycin (Blenoxane)
FDA Link
Generic
01/2021 - 06/2016
3
tremelimumab
IBA
12/2020 - 01/2019
3
durvalumab
IBA
12/2020 - 01/2019
3
Chorionic Gonadotropin (Human Chorionic Gonadotropin)
FDA Link
Generic
01/2020 - 02/2016
3
Methotrexate (Mexate)
FDA Link
Generic
01/2017 - 06/2014
3
Taxoids (Taxanes)
IBA
04/2016 - 06/2015
3
pazopanib
FDA Link
02/2016 - 08/2012
2
Phosphotransferases (Kinase)
IBA
04/2024 - 06/2015
2
olaparib
IBA
06/2023 - 01/2018
2
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
04/2023 - 12/2021
2
Messenger RNA (mRNA)
IBA
01/2023 - 07/2019
2
sacituzumab govitecan
IBA
10/2022 - 12/2021
2
Antigens
IBA
10/2022 - 01/2022
2
Epithelial Cell Adhesion Molecule
IBA
10/2022 - 10/2016
2
Creatinine
IBA
01/2021 - 01/2019
2
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
11/2020 - 11/2019
2
Immunoglobulin G (IgG)
IBA
01/2020 - 01/2017
2
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2020 - 11/2017
Therapy/Procedure
105
Drug Therapy (Chemotherapy)
01/2024 - 08/2009
83
Therapeutics
04/2024 - 08/2011
46
Immunotherapy
05/2024 - 09/2016
46
Cystectomy
05/2024 - 08/2015
33
Lymph Node Excision (Lymph Node Dissection)
04/2024 - 10/2011
33
Neoadjuvant Therapy
10/2023 - 08/2015
19
Adjuvant Chemotherapy
12/2022 - 01/2015
10
Nephroureterectomy
10/2022 - 01/2017
10
Salvage Therapy
01/2021 - 06/2011
6
Radiotherapy
01/2024 - 12/2012
5
Nephrectomy
04/2024 - 01/2019
4
Castration
06/2023 - 10/2021
4
Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 04/2016
4
Orchiectomy (Orchidectomy)
06/2021 - 12/2012
3
Adjuvant Radiotherapy
05/2023 - 01/2018
3
Transplantation
01/2018 - 03/2016
2
Precision Medicine
03/2024 - 01/2018
2
Chemoradiotherapy
01/2023 - 12/2014
2
Gas Lasers
05/2022 - 01/2017
2
Operative Surgical Procedures
01/2022 - 10/2021
2
Aftercare (After-Treatment)
01/2021 - 01/2017